Sanofi Stock Performance
as on September 18, 2025 at 8:40 pm IST
Day's Low
Day's High
$47.02$47.3
0.38%
Downside
0.21%
Upside
52 Week's Low
52 Week's High
$44.73$60.125.23%
Downside
27.36%
Upside
Sanofi share price movements today
- Previous Close
- $46.97
- Open
- $47.19
- Volume
- 358.1K
- Day's Low - High
- $47.02 - $47.3
- 52 Week Low - High
- $44.73 - $60.12
Sanofi Historical Returns
- 1 Month Return
- -5.76 %
- 3 Month Return
- -1.36 %
- 1 Year Return
- -18.27 %
- 3 Year Return
- + 15.07 %
- 5 Year Return
- -10.43 %
Sanofi Stock Fundamentals & Key Indicators
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$114.2B
EPS (TTM)
4.6154
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
2.67%
PE Ratio (TTM)
15.52
Industry PE ratio
16.65525641025641
P/B Ratio
15.5166
PEG Ratio
0.723
EBITDA
12.1B
Revenue (TTM)
45.7B
Profit Margin
19.95%
Return On Equity TTM
9.00%
Sanofi Stock Valuation
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Today (15.52x)
September 18, 2025
Industry (16.66x)
September 18, 2025
Highest (15.05x)
September 30, 2020
Today’s Price to Earnings Ratio: 15.52x
Sanofi vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $114.2B | -10.43% | 15.52 | 19.95% | |
| BUY | $681.4B | 393.05% | 49.71 | 25.91% | |
| BUY | $390.1B | 145.04% | 105.15 | 6.45% | |
| BUY | $247.9B | 67.63% | 14.59 | 35.61% | |
| BUY | $426.8B | 18.78% | 18.97 | 25.00% |
Stock Returns calculator for Sanofi Stock including INR - Dollar returns
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹87,083
Returns
Returns from Sanofi Stock
Dollar Returns*
₹4,953 (+4.95%)
Analyst Recommendation on Sanofi Stock
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $61.61
Sanofi Share Price Target
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
23.39%UPSIDE
Target Price
$61.61
Current Price
$47.2
Analyzed by
31 Analysts
Target
$61.61
Sanofi target price $61.61, a slight upside of 23.39% compared to current price of $47.2. According to 31 analysts rating.
Sanofi Stock's Interest Amongst Investors
Investment in Sanofi Shares on INDmoney has grown by 138.15% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:138.15% versus previous 30 day period
Search interest for Sanofi Stock has increased by 44% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:44% versus previous 30 day period
Sanofi Quarterly Profit & Loss
All numbers in Millions USD
Sanofi Annual Profit & Loss
All numbers in Millions USD
Sanofi Quarterly Cash Flow
All numbers in Millions USD
Sanofi Annual Cash Flow
All numbers in Millions USD
Sanofi News & Key Events
Today's Timeline - 17 September
Wed, 11:03 AM
-Sanofi reports positive Phase 2a data for Brivekimig in treating hidradenitis suppurativa, showing significant efficacy.
Wed, 02:35 PM
-Analyst maintains Buy rating on Sanofi, citing promising Brivekimig data and potential for Tolebrutinib in SPMS market.
Wed, 06:52 PM
-Sanofi stock fell due to tariff concerns and mixed Phase 3 trial results, with a one-month return of -7.26%.
Today's Timeline - 17 September
Wed, 10:00 PM
-Sanofi's Tzield approved in China for type 1 diabetes, enhancing its product offerings and market position.
Thu, 01:04 AM
-Sanofi shares new data on Brivekimig, showing strong efficacy in treating hidradenitis suppurativa in biologic-naïve patients.
Thu, 01:35 AM
-Sanofi stock upgraded to Buy with a $58 target, citing attractive entry point and strong sales momentum.
Today's Timeline - 17 September
Thu, 03:01 AM
-Dupixent dominates market, targeting IL-4 and IL-13, approved for various type 2 inflammatory conditions.
Insights on Sanofi
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Sanofi has shown strong performance in its net profit over the last three quarters. The net profit increased from $499.0 million to $3.94 billion, demonstrating a remarkable average growth of 62.9% per quarter.
- POSITIVE IMPACT
Revenue Rich
Sanofi has shown positive revenue trends over the last three quarters. Its revenue increased from $7.63 billion to $10.73 billion, reflecting an average growth of 14.6% per quarter.
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly And Company has given 53.3% return, outperforming this stock by 38.2%
- NO EFFECT
Against Peers
In the last 1 year, Abbvie Inc has given 14.4% return, outperforming this stock by 32.7%
NEGATIVE IMPACTPrice Dip
In the last 1 month, SNY stock has moved down by -5.8%
About Sanofi
| Organisation | Sanofi |
| Headquarters | 46, avenue de la Grande Armée, Paris, France, 75017 |
| Industry | Health Technology |
| CEO | Mr. Paul Hudson |
| E-voting on shares | Click here to vote |
Key Management of Sanofi
Name | Title |
|---|---|
Mr. François-Xavier Roger | Executive VP & CFO |
Mr. Olivier Charmeil | Executive Vice President of General Medicines |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Mr. Felix Lauscher | Head of IR North America & Asia |
Mr. Paul Hudson | CEO & Director |
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Mr. Thomas Kudsk Larsen | Head of Investor Relations |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Ms. Natalie Bickford | Executive VP & Chief People Officer |
FAQs
What is Sanofi share price today?
Sanofi share price today is $47.2 as on . Sanofi share today touched a day high of $47.3 and a low of $47.02.
What is the 52 week high and 52 week low for Sanofi share?
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $44.73 on . Sanofi stock price today i.e. is trending at $47.2,which is 21.48% down from its 52 week high and 5.52% up from its 52 week low.
What is Sanofi's market capitalisation today?
Sanofi market capitalisation is $0.11T as on .
How to invest in Sanofi Stock (SNY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Sanofi on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sanofi Shares that will get you 0.0318 shares as per Sanofi share price of $47.2 per share as on September 18, 2025 at 8:40 pm IST.
What is the minimum amount required to buy Sanofi Stock (SNY) from India?
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $47.2 as on September 18, 2025 at 8:40 pm IST, you will get 0.2119 shares of Sanofi. Learn more about
fractional shares .
What are the returns that Sanofi has given to Indian investors in the last 5 years?
Sanofi stock has given -10.43% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?